Expanding the Philadelphia Cell and Gene Therapy Hub

January 28, 2022 PAO-01-22-R250-09

In this group interview, Maria P. Limberis, Ph.D. and Roland Kolbekc, Ph.D. from Spirovant Sciences; Parviz Shamlou, Ph.D., of Thomas Jefferson University / the Jefferson Institute of Bioprocessing, Dave Goswami of IPS, and Claire Greenwood of the CEO Council for Growth discuss how Greater Philadelphia has become one of the leading hubs for cell and gene therapy development and how they are maintaining that momentum.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: